Core Insights - Black Swan Graphene Inc. has completed a significant production capacity expansion at its facility in Consett, UK, tripling its production capacity [1][2] - The new production unit utilizes a customized 3160 Ariete System from GEA Group AG, marking a major milestone in the company's industrial-scale manufacturing of Graphene Nanoplatelets [2][3] Production Capacity and Capabilities - The annual manufacturing capacity has increased to over 140 tonnes of Graphene Nanoplatelets, up from 40 tonnes, based on a continuous three-shift operation [3] - The industrial flow rates can reach up to 22,000 litres per hour, facilitating large-scale production [3] Strategic Positioning - This expansion solidifies Black Swan's leadership in the high-quality Graphene Nanoplatelets market and transitions the company from pilot-scale to full industrial-scale manufacturing [2][3] - The enhanced capacity supports the production of the GraphCore™ product line, which underpins the company's Graphene Enhanced Masterbatch™ offerings [5] Development and Commercialization - Black Swan now provides a fully integrated in-house development and production platform, allowing customers to move seamlessly from laboratory testing to high-volume commercial procurement [4] - The company has established a robust global distribution network through partnerships with leading industry participants, enhancing its market reach [6] Company Background - Black Swan focuses on large-scale production and commercialization of patented high-performance graphene products aimed at various industrial sectors [7] - The company's graphene processing technology has been developed over the last decade in collaboration with Thomas Swan & Co. Ltd, a reputable global chemicals manufacturer [7]